Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TNYA Tenaya Therapeutics Inc

Pre-Mkt 07-10 06:36:55 EDT

0.8500

-0.0299

-3.40%

盘前0.8500

+0.00000.00%

04:48 EDT

High0.9470	Low0.8500	Vol3.58M
Open0.8803	D1 Closing0.8799	Amplitude11.02%
Mkt Cap184.03M	Tradable Cap174.97M	Total Shares216.51M
T/O3.20M	T/O Rate1.74%	Tradable Shares205.84M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TNYA","market":"US","secType":"STK","nameCN":"Tenaya Therapeutics Inc","latestPrice":0.85,"timestamp":1783627200000,"preClose":0.8799,"halted":0,"volume":3575815,"hourTrading":{"tag":"盘前","latestPrice":0.85,"preClose":0.85,"latestTime":"04:48 EDT","volume":3939,"amount":3348.67530504,"timestamp":1783673338654,"change":0,"changeRate":0,"amplitude":0.034353},"delay":0,"changeRate":-0.033981134219797746,"floatShares":205841252,"shares":216505900,"eps":-0.461845,"marketStatus":"Pre-Mkt","change":-0.0299,"latestTime":"07-10 06:36:55 EDT","open":0.8803,"high":0.947,"low":0.85,"amount":3201652.803426,"amplitude":0.11024,"askPrice":0.93,"askSize":80,"bidPrice":0.79,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.461845,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783690200000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.85,"preClose":0.85,"latestTime":"04:48 EDT","volume":3939,"amount":3348.67530504,"timestamp":1783673338654,"change":0,"changeRate":0,"amplitude":0.034353},"postHourTrading":{"tag":"盘后","latestPrice":0.868,"preClose":0.85,"latestTime":"19:55 EDT","volume":68044,"amount":58488.769691,"timestamp":1783641335519,"change":0.018,"changeRate":0.021176,"amplitude":0.034353},"volumeRatio":0.8716141486072828,"impliedVol":4.0921,"impliedVolPercentile":0.968},"requestUrl":"/m/hq/s/TNYA","defaultTab":"news","newsList":[{"id":"2649265336","title":"Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649265336","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649265336?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:20","pubTimestamp":1783336818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX) and Tenaya Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4539","LABU","XLV","CATX","BK4581","LU0029874061.USD","HCSG","TNYA","LU0128526141.USD","BK4585","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636120","title":"Tenaya Therapeutics Ends Manufacturing Center Lease, Shifts Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636120?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:36","pubTimestamp":1783028202,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Tenaya Therapeutics ( ($TNYA) ). On June 29, 2026, Tenaya Therapeutics, Inc. agreed to terminate its lease for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-ends-manufacturing-center-lease-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-ends-manufacturing-center-lease-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648635959","title":"Tenaya Therapeutics to Terminate Union City Manufacturing Lease, Forfeits $1.75 Million Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=2648635959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648635959?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:02","pubTimestamp":1783026120,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics to terminate Union City manufacturing lease, forfeits $1.75 million depositTenaya Therapeutics entered a lease termination agreement for its Union City, California genetic medicine","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL8cD2dh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372749","title":"Tenaya Therapeutics Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372749","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372749?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:30","pubTimestamp":1782739846,"startTime":"0","endTime":"0","summary":"An update from Tenaya Therapeutics ( ($TNYA) ) is now available. Tenaya Therapeutics, a clinical-stage biotech developing genetic medicines for hea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TNYA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647374088","title":"Tenaya Therapeutics Names Eric Hyllengren CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2647374088","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647374088?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:09","pubTimestamp":1782738553,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics (TNYA) said Monday that it has appointed Eric Hyllengren as Chief Financial Officer, starting July 13.Tenaya said Hyllengren was most recently CFO of Zura Bio (ZURA).","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TNYA","BK4539","ZURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647741083","title":"Tenaya Therapeutics appoints Eric Hyllengren as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2647741083","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647741083?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:01","pubTimestamp":1782738096,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics (TNYA) announced the appointment of Eric Hyllengren as CFO, effective July 13. In this role, he will oversee financial strategy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-appoints-eric-hyllengren-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-appoints-eric-hyllengren-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371946","title":"Press Release: Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371946","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371946?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","TNYA","BK4585","BK4531","BK4539","HCM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641016464","title":"Tenaya Therapeutics posts Jefferies healthcare conference deck on heart disease gene therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2641016464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641016464?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:23","pubTimestamp":1780601035,"startTime":"0","endTime":"0","summary":"Tenaya highlighted 2026 catalysts to advance TN-201 and TN-401 toward pivotal-study planning, with regulatory endpoint and design updates expected in 2H 2026.TN-201 MyPEAK-1 interim data showed improvement across biomarkers, hypertrophy measures, symptom scores, and functional capacity, with durability out to 2 years in Cohort 1.All evaluable TN-201 patients achieved LVMI reductions; Cohort 2 showed declines as early as week 26, including -21% and -25% in two patients.TN-201 safety profile remained consistent, with mostly mild, transient, reversible adverse events; the most common were asymptomatic liver enzyme elevations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL977zlw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640184246","title":"Tenaya Therapeutics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2640184246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640184246?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:45","pubTimestamp":1780519527,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on June 4 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640186238","title":"Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640186238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640186238?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:20","pubTimestamp":1780510843,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","TNYA","XLV","BK4539","BK4588","CABA","LU0029874061.USD","BK4137","LU0128526141.USD","BK4581","XBI","LABU","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640185440","title":"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640185440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640185440?lang=en_us&edition=fundamental","pubTime":"2026-06-04 01:00","pubTimestamp":1780506041,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ligand Pharma (LGND) and Tenaya Therapeutics (TNYA) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","BK4007","BK4539","LGND","BK4139","LU1559883803.SGD","TNYA","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906987","title":"Tenaya Therapeutics - Cohort 1 Benefits Sustained up to Two Years; Cohort 2 Shows Earlier Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906987?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906933","title":"Tenaya Therapeutics - All Evaluable Patients Show Improvements in Mybpc3-Associated HCM After Tn-201 Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906933?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906520","title":"Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment of Mybpc3-Associated HCM With Tn-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906520?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640290640","title":"Tenaya Therapeutics - Tn-201 Well Tolerated With No New Safety Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2640290640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640290640?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640143925","title":"Tenaya Therapeutics to release new interim MyPEAK-1 trial data for TN-201 gene therapy in MYBPC3-associated HCM on June 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2640143925","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640143925?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:33","pubTimestamp":1780432400,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics scheduled new interim data from the MyPEAK-1 Phase 1b/2 trial of TN-201 gene therapy for June 3, 2026.Results have not been presented yet; the update will cover Cohort 1 and Cohort 2 in adults with MYBPC3-associated hypertrophic cardiomyopathy.The readout is positioned as an early look at whether TN-201 shows signs of improving disease-related outcomes in this genetic form of HCM.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL59VFPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B3QW5Z07.USD","NDAQ","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4539","LU2210149790.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK4112","SG9999014005.SGD","BK4588","BK4585","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","TNYA","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925992","title":"Tenaya Therapeutics to Announce New Interim Data From Mypeak™-1 Phase 1B/2 Trial of Tn-201 for Adults With Mybpc3-Associated HCM on Wednesday, June 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925992?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:30","pubTimestamp":1780432200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUABSDM8K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639608802","title":"Tenaya Therapeutics Shareholders Approve Expanded Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2639608802","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639608802?lang=en_us&edition=fundamental","pubTime":"2026-05-30 06:37","pubTimestamp":1780094248,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Tenaya Therapeutics ( ($TNYA) ). On May 27, 2026, Tenaya Therapeutics’ shareholders approved an amended and res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-shareholders-approve-expanded-equity-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-shareholders-approve-expanded-equity-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","TNYA","BK4215","BK4139","BK4588","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677023","title":"Tenaya Therapeutics shareholders approve amended 2021 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677023","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677023?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:05","pubTimestamp":1780088739,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics held its annual shareholder meeting on May 27, 2026.Investors approved an amended and restated 2021 equity incentive plan, effective May 27, 2026, including a one-time increase of 6,509,966 shares.The revised plan also removes the 4 million annual cap on the evergreen increase while keeping the annual increase at 4% of outstanding shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL3Lcpfn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639410622","title":"Tenaya Therapeutics to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2639410622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639410622?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:02","pubTimestamp":1780056138,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 at 3:10 p.m. ET.Company executives are also scheduled to participate in the conference, which runs June 2-4, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL1Hs9fH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","SG9999014021.USD","BK4588","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","BK4585","BK4139","SG9999014039.USD","IE00B3QW5Z07.USD","TNYA","IE00BGHQF748.EUR","BK4539","BK4112","IE00BN0W2V16.EUR","LU0314104364.USD","NDAQ","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenayatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0802},{"period":"1month","weight":0.1972},{"period":"3month","weight":0.2319},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.1947}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.091688},{"month":2,"riseRate":0.2,"avgChangeRate":-0.006231},{"month":3,"riseRate":0.4,"avgChangeRate":-0.077091},{"month":4,"riseRate":0.2,"avgChangeRate":0.069395},{"month":5,"riseRate":0.4,"avgChangeRate":0.046898},{"month":6,"riseRate":0.2,"avgChangeRate":-0.085773},{"month":7,"riseRate":0.6,"avgChangeRate":0.011376},{"month":8,"riseRate":0.4,"avgChangeRate":0.09529},{"month":9,"riseRate":0.4,"avgChangeRate":-0.101393},{"month":10,"riseRate":0.2,"avgChangeRate":-0.046678},{"month":11,"riseRate":0.4,"avgChangeRate":0.123533},{"month":12,"riseRate":0.2,"avgChangeRate":-0.128991}],"exchange":"NASDAQ","name":"Tenaya Therapeutics Inc","nameEN":"Tenaya Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tenaya Therapeutics Inc,TNYA,Tenaya Therapeutics Inc股票,Tenaya Therapeutics Inc股票老虎,Tenaya Therapeutics Inc股票老虎国际,Tenaya Therapeutics Inc行情,Tenaya Therapeutics Inc股票行情,Tenaya Therapeutics Inc股价,Tenaya Therapeutics Inc股市,Tenaya Therapeutics Inc股票价格,Tenaya Therapeutics Inc股票交易,Tenaya Therapeutics Inc股票购买,Tenaya Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}